DataMeds AI, Inc. SEC filings MEDS

DataMeds AI, Inc. has 176 filings in SEC EDGAR's recent list, going back to Jul 22, 2024. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, regulation fd disclosure). The company's fiscal year ends on December 31.

DataMeds AI, Inc. SEC filings
Form Description Filed Period
8-K Current report
Agreement ended, Regulation FD disclosure
Nov 5, 2026 Nov 3, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Oct 26, 2026 Oct 21, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 20, 2026 Oct 19, 2026
8-K Current report
Material agreement, Listing notice, Unregistered share sale
Oct 16, 2026 Oct 13, 2026
8-K Current report
Other events
Oct 13, 2026 Oct 13, 2026
PRE 14C Filing Oct 9, 2026 Oct 9, 2026
S-1/A Amended registration statement Oct 9, 2026 —
8-K Current report
Other events
Sep 17, 2026 Sep 11, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Sep 16, 2026 Sep 11, 2026
PRE 14C Filing Aug 31, 2026 Aug 31, 2026
8-K Current report
Results of operations
Aug 18, 2026 Aug 17, 2026
10-Q Quarterly report Aug 17, 2026 Jun 30, 2026
8-K Current report
Other events
Aug 14, 2026 Aug 14, 2026
NT 10-Q Filing Aug 14, 2026 Jun 30, 2026
S-1 Registration statement Aug 7, 2026 —
8-K Current report
Material agreement
Aug 4, 2026 Jul 29, 2026
8-K Current report
Other events
Jul 29, 2026 Jul 27, 2026
8-K Current report
Bylaw or fiscal year change, Other events
Jul 21, 2026 Jul 20, 2026
4 Insider transaction Jun 25, 2026 Jun 22, 2026
4 Insider transaction Jun 25, 2026 Jun 22, 2026
4/A Filing Jun 25, 2026 Mar 31, 2026
4/A Filing Jun 25, 2026 Mar 31, 2026
PRE 14A Preliminary proxy statement Jun 18, 2026 Jun 18, 2026
8-K Current report
Listing notice, Other events
Jun 12, 2026 Jun 9, 2026
DRS/A Filing Jun 11, 2026 —
8-K/A Amended current report Jun 3, 2026 May 27, 2026
8-K/A Amended current report Jun 2, 2026 May 27, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 29, 2026 May 27, 2026
8-K Current report
Other events
May 21, 2026 May 21, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
May 21, 2026 May 19, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 19, 2026 May 19, 2026
10-Q Quarterly report May 19, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 19, 2026 May 15, 2026
8-K Current report
Other events
May 18, 2026 May 18, 2026
PRER14A Filing May 15, 2026 —
NT 10-Q Filing May 15, 2026 Mar 31, 2026
EFFECT Filing May 7, 2026 —
8-K Current report
Material agreement
May 7, 2026 May 1, 2026
CORRESP Letter to the SEC May 5, 2026 —
8-K/A Amended current report
Material agreement
May 4, 2026 Feb 9, 2026
DEF 14A Proxy statement May 4, 2026 May 4, 2026
CORRESP Letter to the SEC May 1, 2026 —
10-K/A Amended annual report Apr 24, 2026 Dec 31, 2025
PRE 14A Preliminary proxy statement Apr 24, 2026 Apr 24, 2026
4 Insider transaction Apr 23, 2026 Mar 31, 2026
4 Insider transaction Apr 23, 2026 Mar 31, 2026
UPLOAD Letter from the SEC Apr 23, 2026 —
8-K/A Amended current report
Material agreement, Listing notice, Unregistered share sale, Regulation FD disclosure
Apr 21, 2026 Apr 17, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 17, 2026 Apr 17, 2026
S-3 Shelf registration Apr 15, 2026 —
3 Initial insider ownership Apr 10, 2026 Feb 4, 2026
3 Initial insider ownership Apr 9, 2026 Oct 7, 2025
8-K Current report
Material agreement, Other events
Apr 9, 2026 Apr 3, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Apr 7, 2026 Apr 1, 2026
DEF 14C Information statement Apr 3, 2026 Apr 3, 2026
3 Initial insider ownership Apr 2, 2026 Mar 19, 2026
PRER14C Filing Mar 25, 2026 —
PRE 14C Filing Mar 25, 2026 Mar 24, 2026
10-K Annual report Mar 20, 2026 Dec 31, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Mar 11, 2026 Mar 6, 2026
8-K Current report
Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Feb 13, 2026 Feb 4, 2026
DRS Filing Feb 11, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 9, 2026 Feb 4, 2026
8-K Current report
Officer or director change
Feb 5, 2026 Feb 1, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Jan 20, 2026 Jan 16, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Jan 8, 2026 Jan 5, 2026
8-K Current report
Regulation FD disclosure
Dec 19, 2025 Dec 17, 2025
8-K Current report
Listing notice
Dec 16, 2025 Dec 10, 2025
8-K Current report
Regulation FD disclosure
Dec 8, 2025 Dec 8, 2025
8-K Current report
Regulation FD disclosure
Dec 5, 2025 Dec 4, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Nov 26, 2025 Nov 26, 2025
8-K/A Amended current report
Material agreement, Regulation FD disclosure
Nov 26, 2025 Nov 24, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Nov 25, 2025 Nov 24, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 20, 2025 Nov 20, 2025
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
8-K Current report
Auditor change
Nov 17, 2025 Nov 11, 2025
NT 10-Q Filing Nov 14, 2025 Sep 30, 2025
DEF 14C Information statement Oct 31, 2025 Oct 31, 2025
8-K Current report
Other events
Oct 30, 2025 Oct 24, 2025
8-K Current report
Regulation FD disclosure
Oct 27, 2025 Oct 27, 2025
3 Initial insider ownership Oct 24, 2025 Oct 2, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 22, 2025 Oct 21, 2025
PRE 14C Filing Oct 21, 2025 Oct 21, 2025
3 Initial insider ownership Oct 21, 2025 Oct 2, 2025
8-K Current report
Regulation FD disclosure
Oct 17, 2025 Oct 13, 2025
3 Initial insider ownership Oct 14, 2025 Oct 2, 2025
8-K Current report
Officer or director change
Oct 10, 2025 Oct 6, 2025
8-K Current report
Officer or director change
Oct 6, 2025 Oct 1, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Oct 1, 2025 Sep 25, 2025
424B4 Prospectus Sep 29, 2025 —
EFFECT Filing Sep 25, 2025 —
CORRESP Letter to the SEC Sep 23, 2025 —
S-1/A Amended registration statement Sep 22, 2025 —
CORRESP Letter to the SEC Sep 12, 2025 —
S-1/A Amended registration statement Sep 12, 2025 —
UPLOAD Letter from the SEC Sep 10, 2025 —
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 5, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 29, 2025 Aug 28, 2025
S-1/A Amended registration statement Aug 29, 2025 —
CORRESP Letter to the SEC Aug 28, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 22, 2025 Aug 20, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
8-K Current report
Agreement ended, Officer or director change, Regulation FD disclosure
Aug 14, 2025 Aug 8, 2025
NT 10-Q Filing Aug 14, 2025 Jun 30, 2025
UPLOAD Letter from the SEC Aug 8, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 30, 2025 Jul 24, 2025
S-1 Registration statement Jul 24, 2025 —
4 Insider transaction Jul 8, 2025 Jul 2, 2025
8-K Current report
Auditor change
Jul 8, 2025 Jul 7, 2025
3 Initial insider ownership Jul 8, 2025 Apr 10, 2025
8-K Current report
Regulation FD disclosure
May 15, 2025 May 15, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
EFFECT Filing May 7, 2025 —
424B3 Prospectus May 7, 2025 —
CORRESP Letter to the SEC May 6, 2025 —
S-1 Registration statement May 5, 2025 —
8-K Current report
Material agreement, Officer or director change
Apr 24, 2025 Apr 22, 2025
3 Initial insider ownership Apr 24, 2025 Mar 21, 2025
3 Initial insider ownership Apr 23, 2025 Apr 22, 2025
UPLOAD Letter from the SEC Apr 23, 2025 —
UPLOAD Letter from the SEC Apr 23, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 18, 2025 Apr 14, 2025
DRS Filing Apr 15, 2025 —
DRSLTR Filing Apr 14, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure
Apr 11, 2025 Apr 8, 2025
8-K Current report
Unregistered share sale, Regulation FD disclosure
Mar 27, 2025 Mar 21, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
3 Initial insider ownership Mar 21, 2025 Feb 18, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Mar 21, 2025 Mar 17, 2025
3 Initial insider ownership Mar 14, 2025 Feb 18, 2025
3 Initial insider ownership Mar 12, 2025 Feb 18, 2025
424B3 Prospectus Mar 6, 2025 —
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Mar 6, 2025 Feb 28, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 28, 2025 Feb 25, 2025
3 Initial insider ownership Feb 28, 2025 Feb 18, 2025
3 Initial insider ownership Feb 28, 2025 Feb 18, 2025
3 Initial insider ownership Feb 28, 2025 Feb 18, 2025
8-K Current report
Material agreement, Other events
Feb 26, 2025 Feb 20, 2025
3 Initial insider ownership Feb 24, 2025 Feb 18, 2025
3 Initial insider ownership Feb 24, 2025 Feb 18, 2025
424B4 Prospectus Feb 21, 2025 —
CERT Filing Feb 20, 2025 —
8-A12B Filing Feb 18, 2025 —
EFFECT Filing Feb 14, 2025 —
CORRESP Letter to the SEC Feb 14, 2025 —
CORRESP Letter to the SEC Feb 14, 2025 —
S-1/A Amended registration statement Jan 14, 2025 —
S-1/A Amended registration statement Dec 18, 2024 —
CORRESP Letter to the SEC Dec 17, 2024 —
UPLOAD Letter from the SEC Dec 16, 2024 —
CORRESP Letter to the SEC Dec 6, 2024 —
S-1/A Amended registration statement Dec 6, 2024 —
UPLOAD Letter from the SEC Nov 13, 2024 —
S-1/A Amended registration statement Nov 6, 2024 —
CORRESP Letter to the SEC Nov 5, 2024 —
UPLOAD Letter from the SEC Nov 4, 2024 —
FWP Free writing prospectus Oct 30, 2024 —
S-1/A Amended registration statement Oct 21, 2024 —
CORRESP Letter to the SEC Oct 18, 2024 —
UPLOAD Letter from the SEC Oct 15, 2024 —
CORRESP Letter to the SEC Sep 27, 2024 —
S-1/A Amended registration statement Sep 27, 2024 —
UPLOAD Letter from the SEC Aug 29, 2024 —
CORRESP Letter to the SEC Aug 2, 2024 —
S-1/A Amended registration statement Aug 2, 2024 —
UPLOAD Letter from the SEC Aug 1, 2024 —
S-1 Registration statement Jul 22, 2024 —

Showing 176 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
MEDS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tampa, FL
SEC filer status
, Emerging growth company
SEC CIK
2030763
Former names
Wellgistics Health, Inc. (until Jul 21, 2026); Danam Health, Inc (until Sep 27, 2024)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.